Results 181 to 190 of about 677,503 (281)

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study. [PDF]

open access: yesEndocrine, 2021
Kuhn E   +12 more
europepmc   +1 more source

From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. [PDF]

open access: yesTher Adv Med Oncol
Melhorn P   +5 more
europepmc   +1 more source

Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2014
S. Neggers   +10 more
semanticscholar   +1 more source

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2013
F. Gatto   +12 more
semanticscholar   +1 more source

Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study. [PDF]

open access: yesOncologist, 2020
Brighi N   +16 more
europepmc   +1 more source

Editorial: The role of radiotherapy in acromegaly [PDF]

open access: yes, 1997
Herder, W.W. (Wouter) de   +2 more
core   +2 more sources

Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2013
R. Pas   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy